IMC Chicago’s Guardant Health GH Stock Holding History

IMC Chicago’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Buy	13,342 +1,955	+17%	+$213K	﹤0.01%	3034
2026 Q1	$1.05M	Sell	11,387 -2,041	-15%	-$205K	﹤0.01%	3234
2025 Q4	$1.37M	Buy	+13,428	New	+$1.2M	﹤0.01%	2733

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

IMC Chicago's GH Position: Q2 2026 in Review

IMC Chicago increased its Guardant Health (GH) stake by 17% in Q2 2026, buying an estimated $213K and bringing the position to 13,342 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #3034.

IMC Chicago first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

IMC Chicago held 13,342 shares of Guardant Health worth $2M as of Q2 2026.
IMC Chicago bought 1,955 Guardant Health shares in Q2 2026, an estimated $213K.
Guardant Health made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3034 holding.
IMC Chicago first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.